| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Substudies
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
The overall objective of this study is to measure risk factors, symptom patterns and severity, longitudinal course, and associated biomarkers in patients who develop symptoms of post treatment Lyme disease (PTLD) in cohort studies.
- Study Design:
- Prospective Longitudinal Cohort
- Study Type:
- Case-Cohort
- Longitudinal Cohort
- Total number of consented subjects: 321
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: PTLDS Transcriptome
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- John Aucott, MD. Lyme Disease Research Center, Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
-
Funding Sources
- Global Lyme Alliance (GLA). Stamford, CT, USA.
- Bay Area Lyme Foundation (BALF). Portola Valley, CA, USA.
- Steven and Alexandra Cohen Foundation. Stamford, CT, USA.
- Lyme Disease Research Foundation of Maryland. Timonium, MD, USA.
-
Principal Investigator